Abstract
Purpose
This case series and literature review aims to investigate the efficacy and safety of definitive ablative radiation therapy as a treatment modality for non-operable patients with early stage breast cancer. We present two cases demonstrating the potential of this approach to achieve durable responses.
Methods
We assessed the long-term response of two non-operable patients diagnosed with Stage II (cT2N0M) and Stage IA (T1bN0M0) invasive ductal carcinoma (IDC), who were deemed unfit for surgery due to significant co-morbid conditions. Definitive ablative radiation therapy was administered using stereotactic partial breast irradiation with ablative doses delivered in either a single fraction or two fractions. Serial imaging was conducted to assess treatment response and monitor adverse events.
Results
Both patients exhibited notable treatment responses following definitive ablative radiation therapy. The first patient, an 84-year-old woman, experienced a 69% reduction in tumor size over a follow-up period exceeding 2 years. The second patient, an 87-year-old woman, achieved complete resolution of disease on imaging, with no signs of progression even 26 month post-treatment. Both patients tolerated the treatment well, without significant treatment-related adverse events.
Conclusions
Our case series suggests that definitive ablative radiation therapy may serve as a safe and effective treatment option for non-operable patients with early stage breast cancer. The observed durable treatment responses and minimal toxicity support the potential of this approach. Furthermore, a longer interval between ablative radiation therapy and surgery may enhance treatment response, potentially leading to increased complete pathologic response rates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bosma SCJ et al (2020) Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial. Int J Radiat Oncol Biol Phys 106(5):958–967
Charaghvandi RK et al (2017) Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol. BMC Cancer 17(1):181
Gao RW et al (2018) Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient. Pract Radiat Oncol 8(6):361–365
Goldberg M, Whelan TJ (2020) Accelerated Partial Breast Irradiation (APBI): Where Are We Now? Curr Breast Cancer Rep 12(4):275–284
Guidolin K et al (2019) Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. Curr Oncol 26(3):e334–e340
Horton JK et al (2015) Preoperative single-fraction partial breast radiation therapy: a novel phase 1, dose-escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys 92(4):846–855
Karasawa K et al (2020) A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy. Radiat Oncol 15(1):265
Meattini I et al (2020) Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial. J Clin Oncol 38(35):4175–4183
Miljanic M et al (2022) The evolving interplay of SBRT and the immune system, along with future directions in the field. Cancers 14(18):4530
Nichols E et al (2017) Preoperative accelerated partial breast irradiation for early-stage breast cancer: preliminary results of a prospective, phase 2 trial. Int J Radiat Oncol Biol Phys 97(4):747–753
Palta M et al (2012) Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 82(1):37–42
Pérez M et al (2017) Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life. Breast Cancer Res Treat 162(2):329–342
Rahimi A (2023) A Phase I dose escalation study of single fraction ablative pre-operative partial breast (S-PBI) for early stage breast cancer. 2023 12.2.2022 7.31.2019. https://clinicaltrials.gov/ct2/show/NCT04040569
Rahimi A et al (2017) Preliminary results of a phase 1 dose-escalation trial for early-stage breast cancer using 5-fraction stereotactic body radiation therapy for partial-breast irradiation. Int J Radiat Oncol Biol Phys 98(1):196-205.e2
Rahimi A et al (2022) Preliminary results of multi-institutional phase 1 dose escalation trial using single-fraction stereotactic partial breast irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 112(3):663–670
Taghizadeh-Hesary F et al (2023) Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity. J Cancer Res Clin Oncol 149:6719–6741
van der Leij F et al (2015) First results of the preoperative accelerated partial breast irradiation (PAPBI) trial. Radiother Oncol 114(3):322–327
Veluvolu M et al (2020) Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: a case report. Rep Pract Oncol Radiother 25(5):760–764
Zerella MA et al (2022) Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study – a phase I/II clinical trial protocol. BMC Cancer 22(1):358
Zhang-Velten E et al (2022) A How-to compendium for GammaPod treatments, clinical workflow, and clinical program at an early adopting institution. Pract Radiat Oncol 12(3):e177–e182
Funding
No additional funding for this project was acquired.
Author information
Authors and Affiliations
Contributions
All authors contributed significantly to the manuscript and were involved and writing and revision of the manuscript as submitted.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Miljanic, M., Nwachukwu, C. & Rahimi, A. Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer. J Cancer Res Clin Oncol 149, 15553–15559 (2023). https://doi.org/10.1007/s00432-023-05053-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-05053-x